Purpose: Dishevelled EGL-10 and pleckstrin domain-containing protein 5 (DEPDC5) mutations are found in a wide spectrum of focal epilepsies ranging from epilepsy caused by malformation of cortical development to non-lesional epilepsy, including sleep-related hypermotor epilepsy (SHE). A surgical approach has been anecdotally reported in patients with DEPDC5 mutations, but most of these cases had a lesional etiology. Methods: We describe a stereo-EEG (SEEG) study in a patient with drug-resistant/non-lesional SHE. Patient was screened for known mutations associated with SHE. Results: SEEG disclosed bilateral synchronous and independent activity prevailing on the right centralanterior cingulate cortex, without a clear spatially defined epileptogenic zone. Due to the lack of a clear epileptogenic zone, surgery was contraindicated. Years later a DEPDC5 mutation was identified.
Introduction
Focal epilepsy (FE) was long thought to originate from primitive/acquired lesions, whereas genetic factors were more likely to cause generalized epilepsy [1] . This dichotomous oversimplification has been challenged by growing evidence that FE can be due to genetic mutations. The first FE gene to be identified was CHRNA4, implicated in autosomal dominant nocturnal frontal lobe epilepsy [2] , recently renamed sleep-related hypermotor epilepsy (ADSHE) [3] . Since 1995, many groups have reported mutations in other genes causing FE, such as nicotinic acetylcholine receptor mutations (CHRNB2, CHRNA2) and potassium channel (KCNT1) in ADSHE, and LGI1 and RELN mutations in autosomal dominant epilepsy with auditory features (ADEAF). Recently, DEPDC5 mutations were found to be the cause of several FEs, ranging from epilepsy caused by malformation of cortical development (MCD) to non-lesional inherited epilepsy. DEPDC5 mutations have been reported as the main cause of familial focal epilepsy with variant foci (FFEVF) and in 13% of ADSHE families [4] . In particular in FFEVF families fronto-temporal epilepsies are the most frequent phenotype, but extra fronto-temporal/multifocal onset have also been reported [5] . Age of onset of DEPDC5-related epilepsy ranges from infancy to adulthood (mean age 9-14) [4] [5] [6] [7] . In ADSHE families infrequent diurnal seizures have been reported, making the differential diagnosis with FFEVF arduous, especially in small pedigrees [6] . Interestingly, in small series of DEPDC5-ADSHE patients a higher prevalence of diurnal episode (60%) and higher rate of drug-resistance (78%) have been reported compared with classical cohorts of ADSHE patients [6] . Recently a high prevalence of DEPDC5 mutation in a large series of SUDEP cases has also been documented [8] .A surgical approach may be the only effective treatment for MCD-associated drug-resistant FE, which usually requires invasive presurgical study including SEEG, a procedure with major complication rates of 1.2-2.6% [9] . Even if some anecdotal surgical cases with visible/non-visible lesions associated with DEPDC5 mutations have been reported (Supplementary Table) , the appropriate surgical management of genetic FE cases is still debated due to the lack of long-term follow-up data. Cases with a constitutional mutation, which likely affects all brain cells, raise concerns on the utility of resecting the focal epileptogenic zone (EZ). We describe a patient with SHE due to a DEPDC5 mutation whose SEEG study precluded a surgical approach.
Methods and results
We report the case of a 53-year-old woman born by dystocic delivery followed by normal developmental milestones. At the age of ten years, she started to experience seizures in wakefulness during which she turned herself around with a sensation of depersonalization and an odd sensation of dizziness that made her laugh. Since 15 years of age she has had hypermotor seizures confined to sleep and episodic nocturnal wanderings during which she could leave home and walk naked around the neighborhood. The same sensation as the daytime events sometimes preceded the nocturnal episodes. Seizures in wakefulness persisted rarely, changing over time, and characterized by a sensation of instability, of "being on the edge of an abyss opening on the right side", fear, tachycardia and sometimes grasping or repetitive movements of the left arm. Nocturnal attacks persisted at higher frequency in adulthood (up to several times per night) despite trials with different antiepileptic drugs. Daytime seizures became sporadic and often occurred during changes of therapy.
At the age of 37 years, she came to our observation. Neurological examination was unremarkable. She was on therapy with carbamazepine 800 mg and clobazam 20 mg. Interictal and ictal EEG showed epileptiform abnormalities over both fronto-centralparietal regions, with left predominance. During nocturnal videopolysomnographic monitoring, we recorded eight seizures from 2 NREM/REM sleep and one during wakefulness. The events were characterized by purposeless flexi-extension movements of the limb, wider in the legs and with right prevalence, flexion of the right arm behind the head, sometimes accompanied by a right orientation of the head and body, while the left arm was fixed and only in one episode did it appear stiff. The episode in wakefulness was preceded by a warm sensation throughout the body, then she clung to the bed afraid of falling out. Ictal EEG showed a fast nontonic activity over the frontal vertex region without a clear lateralization. Tailored brain MRI (1.5 T) was unrevealing.
Due to the high frequency of the episodes and the risk of the patient harming herself during nocturnal seizures, especially during nocturnal wanderings, at the age of 43 years she underwent presurgical evaluation. Bilateral fronto-temporal SEEG investigation, including the inferior parietal lobe, showed bilateral ictal and interictal epileptiform activity, prevailing on right central-anterior cingulate cortex (H electrode) (Fig. 1) . The ictal activity could be synchronous over the anterior cingulate cortex or arise from both frontal mesial cortices with an electrical pattern suggestive of focal cortical dysplasia [10] . Due to bilateral ictal and inter-ictal activity synchronously/asynchronously involving a wide portion of the mesial fronto-temporal-parietal lobes and unclear anatomoelectroclinical correlation, surgical intervention was rejected. Nine years later, whole exome sequencing identified a pathogenic rare frameshift-mutation in a known SHE gene (DEPDC5; c.492delTCGTT; p.Arg165Tyrfs*14) inherited from her healthy mother (details in [11] , family 18) (Fig. 2) . Mutations in other known SHE-genes (CHRNA4, CHRNA2, CHRNB2 and KCNT1) were excluded.
At the age of 50 an advanced 1.5 T MRI study (spectroscopy, resting-state fMRI) failed to disclose any focal lesions. The hemodynamic response function related to interictal epileptiform discharges did not show any significant alteration due to limited number of interictal abnormalities. At present the patient continues to have weekly seizures during sleep.
Discussion
We report a sporadic case with drug-resistant/non-lesional SHE associated with a DEPDC5 mutation who underwent SEEG study; due to the lack of a reliable EZ, surgical intervention was denied.
The negative family history did not suggest us a genetic etiology, but considering the well known incomplete penetrance of the mutation a genetic etiology should be considered even in sporadic cases of FE [7] . The identification of DEPDC5 mutation could help to discriminate which patient could have a higher risk of developing SUDEP [8] .
To our knowledge, this is the first documented SEEG study on DEPDC5 non-lesional epilepsy. Presurgical evaluation and surgical treatment have been performed in a few patients with DEPDC5 mutation-positive FE, including SHE (Supplementary Table) . Eight patients underwent surgical resection of a dysplastic lesion (FCD I/ II) with a seizure-free rate of 63%. Three of the eight operated patients had a negative MRI examination, two of whom became seizure-free, one after the second surgery and one over 13 years of follow-up (Supplementary Table) . However, some negative MRI results could be explained by the lower resolution of older MRI systems in identifying subtle dysplastic lesions.
In all these patients, the surgical approach was guided by a visible MRI lesion and/or by a clear EZ on SEEG examination. Some of them underwent multiple interventions and wide resection including eloquent cortex, with post-surgical deficits (patients # 2,3,5,7; Supplementary Table) . Subtle invisible dysplastic lesions or a more complex epileptogenic network could not be excluded, at least in patients with a poor surgical outcome. Although our SEEG data were suggestive of FCD, they did not identify a clear EZ. This could be in part explained by the limited SEEG exploration that did not entirely cover the anterior part of the mesial frontal lobe and dorsolateral frontal lobes. However, taking into account the genetic etiology, the preliminary results of DEPDC5 surgery and the strong association with FCD, we cannot exclude our patient had multiple MRI-negative areas of subtle FCD or a wider epileptogenic network involving FCD areas and normalappearing remote areas. Other FCD studies suggest that the main epileptogenic zone could be associated with both a remote dysplastic area and with an aberrant epileptogenic network [12] . The presence of diffuse BOLD alterations worsened the surgical outcome [13] . Even considering other genetic forms of FE, data on the role of genetics as a predictor of surgical outcome are controversial. While some case reports showed a good outcome in pediatric NPRL3-related epilepsy [14] , others demonstrated that a surgical approach gave no benefits, such as in SCN1A-related epilepsy [15] . Other conditions, such as tuberous sclerosis, have their own management. Tuberous sclerosis patients share with DEPDC5 the mutation in the mTOR-pathway, and resection of all epileptogenic tubers and perituber tissue results in a good outcome [16] .
Conclusion
On the grounds of these data, we suggest that a genetic analysis should be entertained in SHE patients with seizures in wakefulness, undefined anatomo-electroclinical correlations and nonlesional drug-resistant epilepsy. If a DEPDC5 mutation is identified, a presurgical evaluation should be tailored to look for a wide epileptogenic network, using advanced neuroimaging tools such as PET, EEG-fMRI or 7T MRI. Due to intrinsic procedural risks, SEEG examination should be considered only in case of limited alterations and should be extended beyond visible abnormalities. In conclusion, a genetic etiology is not an absolute exclusion criterion for surgery, but may require a more comprehensive surgical benefit/risk assessment.
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